Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98,489,676
-
Total 13F shares
-
32,408,019
-
Share change
-
-2,581,930
-
Total reported value
-
$476,115,938
-
Price per share
-
$14.70
-
Number of holders
-
75
-
Value change
-
-$54,519,859
-
Number of buys
-
37
-
Number of sells
-
32
Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q4 2021
As of 31 Dec 2021,
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,408,019 shares.
The largest 10 holders included
FMR LLC, Column Group LLC, EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Invus Financial Advisors, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.